Bioventus Inc (BVS)
6.38
-0.16
(-2.45%)
USD |
NASDAQ |
Jun 14, 16:00
6.36
-0.02
(-0.31%)
After-Hours: 20:00
Bioventus Enterprise Value: 819.44M for June 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 14, 2024 | 819.44M |
| June 13, 2024 | 829.66M |
| June 12, 2024 | 844.98M |
| June 11, 2024 | 829.02M |
| June 10, 2024 | 825.19M |
| June 07, 2024 | 816.25M |
| June 06, 2024 | 846.25M |
| June 05, 2024 | 850.08M |
| June 04, 2024 | 839.87M |
| June 03, 2024 | 839.87M |
| May 31, 2024 | 839.23M |
| May 30, 2024 | 844.98M |
| May 29, 2024 | 846.89M |
| May 28, 2024 | 854.55M |
| May 24, 2024 | 818.81M |
| May 23, 2024 | 816.25M |
| May 22, 2024 | 814.34M |
| May 21, 2024 | 805.40M |
| May 20, 2024 | 809.87M |
| May 17, 2024 | 819.44M |
| May 16, 2024 | 835.40M |
| May 15, 2024 | 817.53M |
| May 14, 2024 | 794.55M |
| May 13, 2024 | 777.32M |
| May 10, 2024 | 756.89M |
| Date | Value |
|---|---|
| May 09, 2024 | 760.72M |
| May 08, 2024 | 733.92M |
| May 07, 2024 | 739.02M |
| May 06, 2024 | 667.53M |
| May 03, 2024 | 665.62M |
| May 02, 2024 | 664.98M |
| May 01, 2024 | 666.90M |
| April 30, 2024 | 664.98M |
| April 29, 2024 | 672.00M |
| April 26, 2024 | 666.26M |
| April 25, 2024 | 672.00M |
| April 24, 2024 | 677.11M |
| April 23, 2024 | 687.32M |
| April 22, 2024 | 686.04M |
| April 19, 2024 | 698.17M |
| April 18, 2024 | 702.64M |
| April 17, 2024 | 712.21M |
| April 16, 2024 | 708.38M |
| April 15, 2024 | 707.75M |
| April 12, 2024 | 703.21M |
| April 11, 2024 | 718.49M |
| April 10, 2024 | 728.67M |
| April 09, 2024 | 734.41M |
| April 08, 2024 | 743.96M |
| April 05, 2024 | 734.41M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
508.22M
Minimum
May 04 2023
1.299B
Maximum
Jan 11 2022
783.55M
Average
739.02M
Median
May 07 2024
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 487.28M |
| Retractable Technologies Inc | -10.82M |
| Xtant Medical Holdings Inc | 120.34M |
| Asensus Surgical Inc | 81.88M |
| Catheter Precision Inc | 2.692M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.57M |
| Revenue (Quarterly) | 129.46M |
| Total Expenses (Quarterly) | 123.84M |
| EPS Diluted (Quarterly) | -0.07 |
| Gross Profit Margin (Quarterly) | 68.27% |
| Profit Margin (Quarterly) | -3.53% |
| Earnings Yield | -5.33% |
| Operating Earnings Yield | 5.10% |
| Normalized Earnings Yield | -4.233 |